<\/p>\n
While no one knows precisely when the first human trials were conducted, the US military is known to have tested MDMA and other drugs on humans in the 1950s. The first \u201crecipe\u201d for MDMA was published in a Polish-language scientific journal in 1960 and tablets began popping up in seized contraband in the 1970s. MDMA\u2019s history began decades before the rave culture that popularized it. A common myth is that it was first synthesized and patented by the German pharmaceutical company Merck as an appetite suppressant. Merck did synthesize the drug in 1912, but the appetite suppressant story is an urban legend.<\/p>\n<\/p>\n
<\/p>\n
Treatment with MDMA was safe and well-tolerated and did not increase the risk of suicidal thoughts or potential for drug misuse. These effects may help treat conditions such as PTSD, as they allow people to talk more openly in therapy about traumatic memories. Serotonin helps to regulate behaviors and functions such as sleep, pain, and appetite and has mood-elevating effects. Research into MDMA therapy as a treatment for eating disorders is also in the initial stages.<\/p>\n<\/p>\n
Some people have reported microdosing MDMA, but it\u2019s possible that long-term use can be toxic. It depletes serotonin levels, and microdosing could leave you with a long hangover. MDMA should be used once a month at most to avoid any dangers of long-term neurotoxicity. Since 1985, the drug has been listed as a Schedule I drug in the US, making it effectively illegal for all uses.<\/p>\n<\/p>\n
<\/p>\n
There is never a good time to take an illegal substance or misuse it. When it comes to the amount of MDMA in a tablet of ecstasy, you never know how much or how little of the drug there is and how you will react to it. If you do use it, take precautions to avoid any accidents such as an overdose. It\u2019s important to know how to reduce risk if you are to do so. Research in animals indicates that this drug, also referred to as MDMA or Molly, is neurotoxic and may affect the brain. Clinical studies suggest that ecstasy may increase the risk of long-term or permanent problems with memory and learning.<\/p>\n<\/p>\n
Meanwhile, the MDMA group had an 83% response rate (10 of 12 patients). Following the treatment, nearly all of those who had received MDMA before psychotherapy no longer met PTSD criteria. The study also found no evidence art therapy for addiction<\/a> of harm to patient health from a single session. Perhaps most remarkably, a long-term follow-up study found that 74% of the patients who had relieved their PTSD symptoms in the first study remained PTSD-free years later.<\/p>\n<\/p>\n Phase three clinical trials are currently taking place, comparing MDMA treatment to current standard-of-care drugs. FDA approval of MDMA-assisted psychotherapy for PTSD is touted addiction relapse<\/a> to be imminent, which would make it ready for market. Ecstasy directly affects your brain\u2019s levels of serotonin (mood), dopamine (energy), and norepinephrine (heart rate).<\/p>\n<\/p>\n